SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-059034
Filing Date
2017-11-14
Accepted
2017-11-14 16:15:28
Documents
41
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv478731_10q.htm 10-Q 333218
2 EXHIBIT 31.1 tv478731_ex31-1.htm EX-31.1 10067
3 EXHIBIT 31.2 tv478731_ex31-2.htm EX-31.2 10446
4 EXHIBIT 32.1 tv478731_ex32-1.htm EX-32.1 4331
5 EXHIBIT 32.2 tv478731_ex32-2.htm EX-32.2 4315
  Complete submission text file 0001144204-17-059034.txt   2063756

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT abeo-20170930.xml EX-101.INS 384592
7 XBRL TAXONOMY EXTENSION SCHEMA abeo-20170930.xsd EX-101.SCH 19546
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abeo-20170930_cal.xml EX-101.CAL 27954
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abeo-20170930_def.xml EX-101.DEF 148776
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE abeo-20170930_lab.xml EX-101.LAB 163970
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abeo-20170930_pre.xml EX-101.PRE 163942
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 171201698
SIC: 2834 Pharmaceutical Preparations